1.
A new RP- HPLC Method Development and Validation for the Concurrent Identification of Nivolumab and Hyaluronidase in Bulk and Pharmaceutical Dosage Form. AJCPR [Internet]. 2025 Jun. 14 [cited 2026 Jun. 16];13(1):47-52. Available from: https://pharmaresearchlibrary.org/journals/index.php/ajcpr/article/view/153